Remeron and Timoptic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Remeron (mirtazapine) and Timoptic (timolol maleate). Common drug interactions include peripheral swelling among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Remeron and Timoptic. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,475 Remeron users. Check the latest studies of Remeron.

What is Timoptic?

Timoptic has active ingredients of timolol maleate. It is often used in glaucoma. eHealthMe is studying from 4,247 Timoptic users. Check the latest studies of Timoptic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

27 people who take Remeron and Timoptic together, and have interactions are studied.

Remeron and Timoptic drug interactions.

What are the common drug interactions of Remeron and Timoptic, by gender? *:

female:

  1. Peripheral swelling
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Confusional state
  4. Decreased appetite
  5. Disturbance in attention
  6. Dizziness
  7. Nausea (feeling of having an urge to vomit)
  8. Vomiting
  9. Abdominal distension
  10. Activities of daily living impaired

male:

  1. Anaemia (lack of blood)
  2. Benign prostatic hyperplasia (benign enlargement of the prostate)
  3. Balance disorder
  4. Blindness unilateral
  5. Blood immunoglobulin a decreased
  6. Blood immunoglobulin g decreased
  7. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  8. Bulimia nervosa (eating disorder characterized by recurrent binge eating, followed by compensatory behaviours)
  9. Cellulitis (infection under the skin)
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Remeron and Timoptic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Axillary mass
  2. Axillary pain
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Oropharyngeal discomfort (pain or irritation of oropharynx)
  6. Peripheral swelling
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Disability

50-59:

  1. Candidiasis (candidiasis or thrush is a fungal infection)
  2. Cellulitis (infection under the skin)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Colonic polyp (extra part of colon tissue grow in intestine)
  5. Cough
  6. Cutis laxa (connective tissue disorder in which the skin lacks elasticity and hangs in loose folds)
  7. Decreased interest
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Dehydration (dryness resulting from the removal of water)
  10. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)

60+:

  1. Fatigue (feeling of tiredness)
  2. Anaemia (lack of blood)
  3. Abdominal distension
  4. Activities of daily living impaired
  5. Benign prostatic hyperplasia (benign enlargement of the prostate)
  6. Constipation
  7. Depressed mood
  8. Drug ineffective
  9. Dry mouth
  10. Eye pruritus (eye itching)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 7 people, 25.93%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 11.11%
  3. Insomnia (sleeplessness): 3 people, 11.11%
  4. High Blood Pressure: 3 people, 11.11%
  5. Drowsiness: 3 people, 11.11%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 11.11%
  7. Parkinson's Disease: 2 people, 7.41%
  8. Osteoporosis (bones weak and more likely to break): 2 people, 7.41%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 7.41%
  10. Haemorrhagic Stroke (stroke caused by the rupture of a blood vessel in the brain): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Remeron and Timoptic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Remeron and Timoptic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Timoptic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remeron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Timoptic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine and timolol maleate (the active ingredients of Remeron and Timoptic, respectively), and Remeron and Timoptic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: